MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/openhrt-2020-001496

Медицинская библиотека · Open heart · 2021

Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantation.

Patterson Tiffany, Hurrell Harriet, Lee Jack, Esposito Giulia, Dutta Utkarsh, Grapsa Julia, Aroney Nicholas, Ahmed-Jushuf Fiyyaz, Allen Christopher, Rajani Ronak, Preston Rebecca, Young Christopher, Lucchese Gianluca, Parmar Kiran, Hunt Beverley, Prendergast Bernard D, Redwood Simon R

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: Durability of transcatheter aortic valve implantation (TAVI) is key to its expansion. We sought to identify incidence of valve thrombosis and predictors of valve thrombosis in our single centre with associated coagulation testing pre-TAVI and post-TAVI.

METHODS AND

RESULTS

This single-centre observational study comprised patients undergoing transfemoral TAVI discussed in the Heart Team meeting . Patients were followed up with echocardiography at 120 days to identify incidence of elevated transvalvular gradient and multivariable analysis was performed to identify factors associated with an increased odds of developing valve thrombosis. In addition, 11 patients underwent baseline, day 1 and day 120 post-TAVI coagulation testing. Between August 2017 and August 2019, 437 consecutive patients underwent transfemoral TAVI. Of these patients, 207/437 (47.4%) had 3-month follow-up echo data available and were analysed. Of these patients, 26/207 (12.6%) had elevated transvalvular gradients. These patients tended to be younger (80±14 vs 83±6 years; p=0.047) with a lower ejection fraction (49±13 vs 54%±11%; p=0.021), with a greater proportion of the population experiencing atrial fibrillation (14/21, 54% vs 68/181, 38%; p=0.067). Following multivariable analysis, there remained a trend towards higher eccentricity index associated with elevated gradients. Baseline (pre-TAVI) elevation of thrombin antithrombin levels (56±63; reference range 1.0-4.1 ng/L) and PF 1+2 (791±632; reference range 69-229 ng/mL) normalised at 120 days post-TAVI

CONCLUSION

This study demonstrated that in the cohort of patients undergoing transfemoral TAVI in our centre: younger age, poor ejection fraction, atrial fibrillation and increased baseline eccentricity of the aortic valve annulus were present to a greater extent in patients exhibiting elevated transvalvular gradients at 3-month follow-up. Further work is required to delineate the extent of coagulation derangement and confirm predictors of thrombosis.

Для цитирования: Patterson Tiffany, Hurrell Harriet, Lee Jack, Esposito Giulia, Dutta Utkarsh, Grapsa Julia, Aroney Nicholas, Ahmed-Jushuf Fiyyaz, Allen Christopher, Rajani Ronak, Preston Rebecca, Young Christopher, Lucchese Gianluca, Parmar Kiran, Hunt Beverley, Prendergast Bernard D, Redwood Simon R. Coagulation derangement and risk factors for valve thrombosis following transcatheter aortic valve implantation.. Open heart. 2021. DOI: 10.1136/openhrt-2020-001496.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.